Johns Hopkins is more than halfway to its $4.5 billion fundraising goal, the university announced Wednesday, with the money helping to support initiatives that include urban revitalization and global health.
More than 162,000 donors have helped Hopkins meet the halfway mark earlier than officials had previously expected, in spring 2014. The $4.5 billion fundraising goal is among the biggest such efforts in the country and the largest for the Johns Hopkins University and Johns Hopkins Hospital.
The Professor Venture Fair began at Bioscience Day 2007 and has become an annual event that gives faculty inventors the opportunity to pitch their new technologies to a team of venture capitalists and entrepreneurs from the region. Presenters are judged based upon clarity of pitch and commercial viability.
Bioscience Day 2013 Venture Fair 11:00 am – 12:00 n
Moderator: Gayatri Varma, Director, OTC
Presenters and INventors: Anthony Melchiorri and John Fisher; Yanjin Zhang; Hadar Ben-Yoav, Reza Ghodssi, Gregory Payne and Deanna L. Kelly ;Kenyon Crowley, Ritu Agarwal , Guodong “Gordon” Gao, Nanette I Steinle and Arnab Ray; Donald DeVoe
Judges:Todd Chappell, Wyatt Somogyi, Matt Cohen, Stephen P. Auvil
Location: Grand Ballroom Lounge, Stamp Student Union
Theme: “The First Mile of a Marathon”. The theme explores the next steps towards commercialization of University developed technologies. Most inventors painstakingly develop their technologies, and yet, underestimate the herculean task of moving an idea from the lab to launch. Even before funding, there is a lot of heavy lifting, analysis, customer discovery, team building, etc. that needs to be done. The panel speakers will discuss these next steps that every inventor or potential entrepreneur has to undertake.
Moderator: Elana Fine, Managing Director, Dingman Center for Entrepreneurship
Panelists: Todd Chappell, Wyatt Somogyi, Matt Cohen, Stephen P. Auvil
Location: Grand Ballroom Lounge, Student Stamp Union, UMCP
In the past few years, pharmaceutical distributor Cardinal Health (NYSE:CAH) has acquired a major distributor and half a dozen pharmaceutical companies in China. It also acquired AssuraMed to enter the home-health supply market, and invested in startups including HealthSpot, which makes a telemedicine kiosk, and Intralign, which helps providers optimize the cost and quality of surgical care.
Those moves were all part of a clearly defined strategy to meet the changing healthcare marketplace. John Rademacher, president of ambulatory care at Cardinal Health, told BioOhio members at the trade group’s annual event on Tuesday that the company’s investment and acquisition strategy is driven by these 12 healthcare industry trends:
Big data may be about to overwhelm the healthcare system. A little healthcare business intelligence tip: Data by itself won’t drive value and outcomes. Smart healthcare analytics will. In Deloitte’s DBrief, “Big Data Revolution: Unlocking Healthcare Analytics,” healthcare industry experts talked about the opportunities and barriers for industries across the care continuum to harness data, contextualize it and use it to move from hindsight to insight (and eventually, with the help of predictive analytics, foresight).
“The future is already here,” Brett Davis, a principal at Deloitte, said. “It just hasn’t been evenly distributed yet.” Here are the six key trends in healthcare shaping how data will be used.
Have a look at a handful of the 50 events that took place during Baltimore Innovation Week 2013. Get involved with Baltimore Innovation Week 2014 here: http://baltimoreinnovationweek.com
The University of Maryland on Wednesday announced the appointment of Thomas R. Fuerst, Ph.D., as the new director of the Institute for Bioscience and Biotechnology Research.
IBBR is a joint research enterprise created to enhance collaboration among the University of Maryland, College Park (UMD), the University of Maryland, Baltimore (UMB), and the National Institute of Standards and Technology (NIST) in the fields of medicine, biosciences, technology, quantitative sciences and engineering.
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
NIH Guide Notice:
Requests for Applications (RFAs):
This NIH Funding Opportunity Announcement (FOA) invites applications to support an Evaluation and Administration Coordinating Center. This unit will facilitate the coordination among and between the awardees of RFA-HL-14-019 “Low-Cost, Pragmatic, Patient-Centered Randomized Controlled Intervention Trials (UH2/UH3)” and the NIH. This unit will also be responsible for conducting an evaluation of the RFA-HL-14-019 program.
This NIH Funding Opportunity Announcement (FOA) invites applications to plan and conduct low-cost, pragmatic randomized controlled trials (RCTs).
Using scores obtained from cognitive tests, Johns Hopkins researchers think they have developed a model that could help determine whether memory loss in older adults is benign or a stop on the way to Alzheimer’s disease.
The risk of developing dementia increases markedly when a person is diagnosed with mild cognitive impairment, a noticeable and measurable decline in intellectual abilities that does not seriously interfere with daily life. But physicians have no reliable way to predict which people with mild cognitive impairment are likely to be in the 5 to 10 percent a year who progress to dementia.
